Leo J. Redmond
Directeur/Bestuurslid bij Presidio Pharmaceuticals, Inc.
Profiel
Leo J.
Redmond is currently the Director at Presidio Pharmaceuticals, Inc. He previously worked as the Senior Director-Finance at Genentech, Inc. from 2000 to 2007.
He also served as the President & Chief Financial Officer at Pharco Pharmaceuticals, Inc. Additionally, Mr. Redmond held the position of Chief Financial Officer & Secretary at The Genentech Foundation from 2004 to 2007.
From 2019 to 2021, he was the Chief Financial & Accounting Officer at Allakos, Inc. Mr. Redmond obtained his undergraduate degree from the University of Kansas and holds an MBA from UCLA Anderson School of Management.
Actieve functies van Leo J. Redmond
| Bedrijven | Functie | Begin |
|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | 01-01-2011 |
Eerdere bekende functies van Leo J. Redmond
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLAKOS INC. | Financieel Directeur/CFO | 01-02-2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Financieel Directeur/CFO | 01-12-2007 |
| The Genentech Foundation | Financieel Directeur/CFO | 01-12-2007 |
| PHARCO PHARMACEUTICALS | Financieel Directeur/CFO | - |
Opleiding van Leo J. Redmond
| University of Kansas | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALLAKOS INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Pharco Pharmaceuticals, Inc.
 Pharco Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharco Pharmaceuticals, Inc. develops, manufactures, markets, distributes, and exports pharmaceutical products. It offers generics and branded generic drugs under the name of Pharco. The company was founded by Hassan Abbas Helmy in 1983 and is headquartered in Alexandria, Egypt. | Health Technology |
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |